CervoMed Inc. Reports Material Agreements and Officer Changes
Ticker: CRVO · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, officer-changes, director-changes, filing
TL;DR
CervoMed filed an 8-K detailing new deals, terminated agreements, and exec changes. Keep an eye on this.
AI Summary
CervoMed Inc. filed an 8-K on April 18, 2025, reporting on several key events that occurred on April 14, 2025. These include entering into a material definitive agreement, terminating a material definitive agreement, and changes related to directors and officers, including compensatory arrangements. The filing also includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate actions, including new agreements and potential changes in leadership or compensation, which could impact the company's strategic direction and financial health.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and changes in officers, which can introduce uncertainty and potential shifts in company strategy.
Key Numbers
- 20250414 — Event Date (Date of earliest event reported in the 8-K)
- 20250418 — Filing Date (Date the 8-K was officially filed with the SEC)
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- 001-37942 (company) — SEC File Number
- 30-0645032 (company) — EIN
- 20250414 (date) — Earliest event reported
- 20250418 (date) — Filing Date
FAQ
What was the nature of the material definitive agreement entered into by CervoMed Inc. on April 14, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details are not provided in the excerpt. Further review of the attached documents would be necessary.
What led to the termination of a material definitive agreement by CervoMed Inc. on April 14, 2025?
The filing states that a material definitive agreement was terminated, but the reasons for termination are not detailed in this summary. The full filing would contain more information.
Were there any changes in CervoMed Inc.'s directors or officers on or around April 14, 2025?
Yes, the filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers, all related to events on or around April 14, 2025.
What is the SIC code for CervoMed Inc. and what industry does it represent?
The SIC code for CervoMed Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What were CervoMed Inc.'s former company names?
CervoMed Inc. was formerly known as Diffusion Pharmaceuticals Inc. (name change effective 20160115), RestorGenex Corp (name change effective 20140307), and Stratus Media Group, Inc (name change effective 20080722).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding CervoMed Inc. (CRVO).